By Harry Peled, Nhu Quyen Dau, Helen Lau First Online: 22 October 2019 In May 2018, Andexxa (coagulation factor Xa [recombinant], inactivated-zhzo or formerly andexanet alfa) received accelerated approval from the Food and Drug Administration (FDA) as a specific reversal for rivaroxaban- and apixaban-treated ...

By Raffaele Aspide, Giacomo Bertolini, Luca Albini Riccioli, Diego Mazzatenta, Giorgio Palandri, Daniele Guerino Biasucci First Online: 03 October 2019 Measuring and monitoring of intracranial pressure is considered standard of care in patients with suspected intracranial hypertension. Sonographic ...

By Stefan W. Leichtle, Anand K. Sarma, Micheal Strein, Vishal Yajnik, Dennis Rivet, Adam Sima, Gretchen M. Brophy First Online: 22 August 2019 Traumatic brain injury (TBI) is one of the leading public health problems in the USA and worldwide. It is the number one cause of death and disability in ...